Skip to main content

Table 2 Characteristics of the studies included in the meta-analysis of the association between SNPs and cardiocerebrovascular diseases

From: Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis

SNP loci

Year

First author

Ethnicity

Cancer/disease

Controla

Sample size (case-control)

Case

Control

OR(95%CI)

Hom†

wild

Het†

Hom

variant

Hom†

wild

Het†

Hom

variant

rs505922

2017

H. Li

Asian

Ischemic stroke

PB

991/1002

511

406

74

657

306

39

1.64(1.41–1.90)

2017

H. Zhang

Asian

Large artery atherosclerotic stroke

PB

644/642

146

325

173

129

322

191

0.90(0.77–1.05)

2016

W. Hernandez

African

Venous Thrombosis

HB

146 /432

–

–

–

–

–

–

1.52(1.20–2.00)

2013

FM.Williams-a‡

Caucasian

Ischemic stroke

HB

4092/8383

–

–

–

–

–

–

1.06(1.01–1.14)

2013

FM.Williams-b‡

Caucasian

Ischemic stroke

HB

8443 /54810

–

–

–

–

–

–

1.07(1.03–1.11)

2011

MP. Reilly

Caucasian

Myocardial infarction

HB

5783/3644

–

–

–

–

–

–

1.20(1.13–1.28)

2009

DA.Trégouet-a§

Caucasian

Venous thromboembolism

PB

419/1228

97

209

113

519

559

150

2.01(1.71–2.35)

2009

DA.Trégouet-b§

Caucasian

Venous thromboembolism

PB

1150/801

299

575

276

339

364

98

1.79(1.57–2.04)

2009

DA.Trégouet-c§

Caucasian

Venous thromboembolism

PB

607/607

177

302

128

265

272

70

1.66(1.41–1.95)

rs657152

2016

W. Hernandez

African

Venous Thrombosis

HB

146 /432

–

–

–

–

–

–

1.39(1.10–1.80)

2011

MP. Reilly

Caucasian

Myocardial infarction

HB

5783/3644

–

–

–

–

–

–

1.19(1.12–1.27)

2009

DA.Trégouet-a§

Caucasian

Venous thromboembolism

PB

419/1228

89

208

122

472

579

177

1.91(1.63–2.24)

2009

DA.Trégouet-b§

Caucasian

Venous thromboembolism

PB

1150/801

276

575

299

318

373

110

1.77(1.55–2.02)

2009

DA.Trégouet-c§

Caucasian

Venous thromboembolism

PB

607/607

171

302

134

249

280

78

1.58(1.34–1.86)

  1. aPB population based control, HB hospital based control; †Hom homozygous, Het heterozygote; a‡ represent the MOnica Risk, Genetics, Archiving and Monograph(MORGAM) and the Wellcome Trust Case Control Consortium 2(WTCCC2) population, b‡ represent MetaStroke population; a§ represent GWAS population from 4 different French centers, b§represent MARseille THrombosis Association study (MARTHA) population, c§represent FARIVE that is a multicenter case-control study